In particular, KRAS is the isoform prevalently mutated in pancreas, lung and colon cancer, while NRAS is the predominant isoform mutated in cutaneous melanomas and acute myelogenous leukemia and HRAS is the predominant isoform mutated in the bladder [9]. Here, NRAS is linked to malignant colon neoplasm.